Bioplastique™ medialization therapy improves the quality of life in terminally ill patients with vocal cord palsy

Clinical Otolaryngology and Allied Sciences

Volumn 27, Issue 5, 2002, Pages 387-391

  Alves, C B ^a   Loughran, S ^a   MacGregor, F B ^a   Dey, J I R ^a   Bowie, L J ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bioplastique; Malignancy; Quality of life; Vocal cord paralysis

Indexed keywords

ELASTOMER; POLYMETHYLSILOXANE; UNCLASSIFIED DRUG; BIOPLASTIQUE; POLYMER;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; PHONATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECORDING; TERMINALLY ILL PATIENT; TREATMENT OUTCOME; VOCAL CORD PARALYSIS; VOICE; HEAD AND NECK TUMOR; INJECTION; LUNG TUMOR; PALLIATIVE THERAPY; PROSPECTIVE STUDY;

AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS; LUNG NEOPLASMS; MALE; PALLIATIVE CARE; POLYMERS; PROSPECTIVE STUDIES; QUALITY OF LIFE; VOCAL CORD PARALYSIS; VOICE QUALITY;

EID: 0036782933     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2002.00601.x     Document Type: Article

References (22)

1. Macgregor F.B., Roberts D.N., Howard D.J. et al. (1994) Vocal fold palsy: A re-evaluation of investigations. J. Laryngol. Otol. 108, 193-196
2. Willat D.J. & Stell P.M. (1989) The prognosis and management of idiopathic vocal cord paralysis. Clin. Otolaryngol. 14, 247-250
3. Terris D.J., Arnstein D.P. & Nguyen H.R. (1992) Contemporary evaluation of unilateral vocal cord paralysis. Otolaryngol. Head Neck Surg. 107, 84-90
4. Benninger M.S., Gillen J.B. & Altman IS. (1998) Changing aetiology of vocal fold immobility. Laryngoscope 108, 346-350
5. Havas I., Lowinger D. & Priestley J. (1999) Unilateral vocal fold paralysis, causes, option and outcomes. Aust. NZ J. Surg. 69, 509-513
6. Ojawa Y., Takashi M. & Hiroshi M. (1990) Recurrent laryngeal nerve paralysis. In Otorhinolaryngology, Head and Neck Surgery, pp. 2021-2024. Kugler & Ghedini Publications, Amsterdam
7. Jacobson B.H., Johnson A., Grywalski C. et al. (1997) The voice handicap index (VHI): Development and validation. Am. J. Speech Lang. Pathol. 6, 66-70
8. Medical Outcomes Study (1989) User's Manual: SF-36 Health Status Questionnaire, Version 1. Quality Quest, Boston, MA
9. Jenkinson C., Wright L. & Coulter A. (1993) A Review of Measures and Population Norms for the UK SF-36. Health Services Research Unit, University of Oxford, Oxford
10. Ware J.E. & Sherbourne C.D. (1992) The MOS 36-Item short form health survey (SF-36). Med. Care 30, 473-483
11. Ersek R.A., Gregory S.R. & Salisbury A.V. (1997) Bioplastique at 6 years: Clinical outcome studies. Plast. Reconstr. Surg. 100, 1570-1574
12. Sittel C., Thumfart W.F., Pototschnig C. et al. (2000) Textured polydimethylsiloxane elastomers in the human larynx: safety and efficiency of use. J. Biomed. Mat. Res. 53, 646-650
13. Dejonckere P.H. (1998) Teflon injection and thyroplasty: objective and subjective outcomes. Rev. Laryngol. Otol. Rhinol. 119, 265-269
14. Shaw G.Y., Szewczyk M.A., Searle J. et al. (1997) Autologous fat injection into the vocal folds: Technical considerations and long-term follow up. Laryngoscope 107, 177-186
15. Chu P.Y. & Chang S.Y. (1997) Transoral teflon injection under flexible laryngovideostroboscopy for unilateral vocal fold paralysis. Ann. Otol. Rhinol. Laryngol. 106, 783-786
16. Harries M.L. & Morrison M. (1998) Management of unilateral vocal cord paralysis by injection medialization with Teflon paste. Quantitative results. Ann. Otol. Rhinol. Laryngol. 107, 332-336
17. D'Antonio L.L., Wigley T.L. & Zimmerman G.J. (1995) Quantitative measures of laryngeal function following Teflon injection or thyroplasty type I. Laryngoscope 105, 256-262
18. Livesey J.R. & Carding P.N. (1995) An analysis of vocal cord paralysis before and after Teflon injection using combined glottography. Clin. Otolaryngol. 20, 423-427
19. Hogikyan N.D., Wodchis W.P., Terrell J.E. et al. (2000) Voice-related quality of life (V-RQOL) following type I thyroplasty for unilateral vocal fold paralysis. J. Voice 14, 378-386
20. Hajioff D., Rattenbury H., Carrie S. et al. (2000) The effect of Isshiki type 1 thyroplasty on quality of life and vocal performance. Clin. Otolaryngol. 25, 418-422
21. Benninger M.S., Ahuja A.S., Gardner G. et al. (1998) Assessing outcomes for dysphonic patients. J. Voice 12, 540-550
22. Kraus D.H., Ali M.K., Ginsberg R.J. et al. (1996) Vocal cord medialization for unilateral paralysis associated with intrathor-acic malignancies. J. Thorac. Cardiovasc. Surg. 111, 334-339